Wearable Medical Devices Market is expected to display major gains reflecting a CAGR of approximately 7% in upcoming decade over 2031 fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.
The Centers for Medicare and Medicaid Services announced Tuesday it plans to cover Aduhelm, a monoclonal antibody treatment for Alzheimer’s disease, only if patients are enrolled in ongoing clinical trials cleared by CMS.
The FDA issued a warning letter to the company at the beginning of October saying that the company marketed the product in the United States "without marketing clearance or approval" which is in violation of the Federal Food, Drug, and Cosmetic Act, according to the FDA.